Integrating molecular docking and molecular dynamics simulation approaches for investigation of the affinity and interactions of quercetin with Class D beta-lactamase, OXA-10

Main Article Content

Fardeen Mohammadi
Abdul Musawer Bayan
Abdul Wakil Qarluq


Introduction: The misuse of β-lactam antibiotics has led to the development of β-lactamase-producing organisms, which inhibit β-lactam activity by hydrolyzing the peptide bond. This study aims to investigate the inhibitory effect of quercetin, a natural composite and isoquinoline alkaloid, on β-lactamase enzyme action, potentially increasing antibiotic effectiveness.

Materials and Methods: This study utilized computational techniques like molecular docking and MD simulation to predict the binding mode and possible conformation poses of quercetin with the OXA-10 β-lactamase enzyme. Autodock software was used for docking, while Gromacs 2019.6 package was used for MD simulations to study molecular complex behavior over time.

Results: The outcomes of the molecular docking analysis revealed a favorable interaction between quercetin and the OXA-10 β-lactamase enzyme, as evidenced by a binding energy of -5.95 kcal/mol and a suitable binding mode. MD simulations confirmed the docking results, showing stable hydrogen bonds between Quercetin and OXA-10, as well as comparable RMSD, RMSF, SASA values, and other parameters. 

Discussion: This research shows the potential of quercetin, a natural compound with multiple medicinal effects, as a possible inhibitor of the class D type β-lactamase OXA-10. Therefore, this study maintains valuable intuition for designing new inhibitors of antimicrobial resistance to combat β-lactamase activity.

Article Details

How to Cite
Mohammadi, F., Bayan, A. M., & Qarluq, A. W. (2024). Integrating molecular docking and molecular dynamics simulation approaches for investigation of the affinity and interactions of quercetin with Class D beta-lactamase, OXA-10. Afghanistan Journal of Infectious Diseases, 2(2), 19–26.
Research Article


Golkar Z, Bagasra O, Pace DG. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. The Journal of Infection in Developing Countries. 2014;8(02):129-36.

Spellberg B, Gilbert DN. The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clinical infectious diseases. 2014;59(suppl_2):S71-S5.

Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Frontiers in public health. 2014;2:145.

Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis. Current opinion in pharmacology. 2014;18:56-60.

Luyt C-E, Bréchot N, Trouillet J-L, Chastre J. Antibiotic stewardship in the intensive care unit. Critical care. 2014;18:1-12.

Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clinical infectious diseases. 2013;56(10):1445-50.

Walther-Rasmussen J, Høiby N. OXA-type carbapenemases. Journal of antimicrobial chemotherapy. 2006;57(3):373-83.

Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annual review of microbiology. 2011;65:455-78.

Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrobial agents and chemotherapy. 2010;54(1):24-38.

Antunes NT, Fisher JF. Acquired Class D β-Lactamases. Antibiotics (Basel). 2014;3(3):398-434.

Berendonk TU, Manaia CM, Merlin C, Fatta-Kassinos D, Cytryn E, Walsh F, et al. Tackling antibiotic resistance: the environmental framework. Nature reviews microbiology. 2015;13(5):310-7.

Gupta M, Mazumder U, Gomathi P, Selvan VT. Antiinflammatory evaluation of leaves of Plumeria acuminata. BMC Complementary and alternative medicine. 2006;6(1):1-6.

Anand David AV, Arulmoli R, Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn Rev. 2016;10(20):84-9.

Sousa da Silva AW, Vranken WF. ACPYPE-Antechamber python parser interface. BMC research notes. 2012;5:1-8.

Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic acids research. 2000;28(1):235-42.

Chen Y, Shoichet BK. Molecular docking and ligand specificity in fragment-based inhibitor discovery. Nature chemical biology. 2009;5(5):358-64.

Mosawi SH, Mansoori H, Bayan AM, Fani N. Molecular docking and dynamics simulation of piperine as a potential inhibitor of class C beta-lactamase. Afghanistan Journal of Infectious Diseases. 2023;1(1):27-32.

Olsen L, Pettersson I, Hemmingsen L, Adolph H-W, Jørgensen FS. Docking and scoring of metallo-β-lactamases inhibitors. Journal of computer-aided molecular design. 2004;18:287-302.

Bayan AM, Mosawi SH, Fani N, Behrad MS, Mehrpoor AJ, Noori MY, et al. Integrating molecular docking and molecular dynamics simulation studies on the affinity and interactions of piperine with β-lactamase class A enzymes. Journal of Molecular Structure. 2023;1292:136151.

Behbood K, Bayan AM, Azizi ZA, Shafiee N, Qarluq AW. Inferring the affinity and interactions of quercetin with Class C β-lactamase (AmpC, pdb code: 4HEF) by integrating molecular docking and molecular dynamics simulation approaches. Afghanistan Journal of Basic Medical Science. 2023;1(1):11-8.